Akintoye, Sunday O.Hersh, Elliot V.2023-05-222023-05-222016-05-182018-08-02https://repository.upenn.edu/handle/20.500.14332/9376Dental management of osteoporosis patients on anti-resorptive therapy can be challenging for both the dentist and physician because of the risk of osteonecrosis of the jaw (ONJ). This editorial reflects on the paper written by Tagushi et al that expressed a relative lack of communication between health care providers when treating osteoporosis patients. Osteoporosis-related bone fractures can be debilitating and occasionally lethal, but management with anti-resorptives is vital while cognizant of the complication of ONJ that can also negatively impact patient’s quality of life.This is an Accepted Manuscript of an article published by Taylor & Francis in [Current Medical Research and Opinion] [May 18 2016], available online: https://dx.doi.org/10.1080%2F03007995.2016.1185401Osteoporosisanti-resorptive therapiesosteonecrosis of the jawbisphosphonatescommunication between physicians and dentistsDentistryArticle